Moreover, FoxO1 is involved in metabolic regulation, and its dysfunction is linked to metabolic disorders associated with liver diseases, such as steatosis and NAFLD, thereby increasing the risk of fibrosis [53,54]. Here, FOXO1 is linked to steatosis.